Diabetes Mellitus - Type 1, Phase II

Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus (TN-22)

Volunteers
Health Professionals

What is the purpose of this trial?

The study is a 2-arm, double blinded, multicenter, 2:1 randomized, placebo controlled clinical trial. Subjects will receive hydroxychloroquine or placebo and close monitoring for progression of T1D.

Trial with
National Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
Ages
3 years and older
Gender
Both

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Melinda Zgorski

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Jennifer Sherr, MD, PhD
Professor in Pediatrics (Endocrinology)

Sub-Investigators

Last Updated
09/12/2023
Study HIC
#2000023905